Humacyte, Inc.
HUMA · Micro Cap · NASDAQ · Healthcare · Biotechnology
$0.58−$0.00 (-0.31%)
Market openRegular session is liveFree AI brief
Get the full brief on HUMA
Free to track. No card required. Usually ready in 10-15 minutes.
Where HUMA sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$0.55
High$2.84
Today $0.58
RSI (14)
45.1Neutral
03070100
Stocksbrew score
55/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$0.58
Lowest
$1
Median target
$1.25
Highest
$4
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Current ratio
Strong · Good liquidity position
6.21x
⚠ Things to watch
Price / sales
Rich · Overpriced by revenue
76.70x
ROIC
Weak · Weak capital efficiency
-74.2%
ROE
Needs attention · Unfavorable
-547.9%
Debt / equity
Needs attention · Unfavorable
2.14x
How it stacks up against its peers
HUMA against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $162.68M | - | +159.3% | 55 |
 | $9.95B | 18.9 | +19.7% | 78 |
 | $33.72B | 35.3 | +15.5% | 78 |
 | $4.12B | 12.4 | +13.5% | 78 |
 | $1.09T | 39.2 | +49.6% | 77 |